1 / 11

Topics to be Discussed at SMRB Meeting

Topics to be Discussed at SMRB Meeting. Lawrence A. Tabak, DDS, PhD Acting Deputy Director, NIH. National Institutes of Health Reform Act of 2006.

dbeasley
Download Presentation

Topics to be Discussed at SMRB Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Topics to be Discussed at SMRB Meeting Lawrence A. Tabak, DDS, PhD Acting Deputy Director, NIH

  2. National Institutes of Health Reform Act of 2006 • Reauthorization bill passed Congress with unanimous support, affirming importance of NIH and its vital role in advancing biomedical research to improve the health of the Nation • Signed into law by the President (1/07)

  3. NIH Reform Act Established: Scientific Management Review Board Mission: • Advise the NIH Director • Conduct continuous comprehensive organizational reviews of NIH and reports findings to DHHS and Congress at least every seven years

  4. SMRB Composition • NIH Director – permanent ex officio, nonvoting member • Voting Members • Odd number of additional voting members, not to exceed 21 members, overlapping terms of 5 years • 9 Institute and Center Directors • 12 Non-federal members • Chair—2 year term, selected from non-federal members

  5. Members of the SMRB • Norman Augustine, Lockheed Martin—Chairman • Jeremy Berg, NIGMS • William R. Brody, Johns Hopkins University • Gail Cassell, Eli Lilly • Anthony Fauci, NIAID • Dan Goldin, former NASA administrator • Richard Hodes, NIA • Stephen Katz, NIAMS • Thomas Kelly, Sloan-Kettering Institute • Story Landis, NINDS • Elizabeth Nabel, NHLBI • John E. Niederhuber, NCI

  6. Members of the SMRB (continued) • Deborah Powell, University of Minnesota Medical School • Griffin Rodgers, NIDDK • William Roper, University of North Carolina • Arthur Rubenstein, University of Pennsylvania School of Medicine • Solomon H. Snyder, Johns Hopkins University • Lawrence Tabak, NIDCR • Eugene Washington, University of California, San Francisco • Huda Zoghbi, Baylor College of Medicine

  7. SMRB Legislation: Activities Issue report not less than once every 7 years • SMRB activities include: • Evaluating NIH research portfolio • Determining pending scientific opportunities and public health needs relevant to the NIH mission • Assessing organizational issues, including: • Use of organizational authorities, including reorganizing and restructuring areas within NIH • Budgetary and operational consequences of any proposed changes • Recommendations on allocation of resources among the ICs

  8. SMRB Legislation: Consultations • SMRB expected to consult with: • IC and Center Directors not on the SMRB • NIH scientific leaders not on the SMRB • IC and Center advisory councils • Scientific organizations • Patient organizations

  9. SMRB Legislation: Meetings and Forums • Meetings • Meet at the call of the Chair or the NIH Director • Not fewer than 5 times with respect to issuing any particular Report • Summary of meetings must be posted on the NIH website • Forums—for Reports on Organizational Issues • With scientific community: needs and opportunities related to proposal for organizational changes (1 or more) • With consumer organizations: needs and opportunities of patients and their families related to proposals for organizational changes (1 or more)

  10. Potential Areas for First Efforts of the SMRB: • NIH Intramural Research Program (IRP) • Overview – DDIR • CC- Dr. John Gallin, Director CC • IRP – Dr. Michael Gottesman, DDIR • Potential Merger of NIAAA and NIDA • Overview – (A)DEPD • Dr. Nora Volkow, Director, NIDA • Dr. Ken Warren, Acting Director, NIAAA

  11. Goal of the Meeting with regard to Potential Merger of NIAAA and NIDA • It is anticipated that the SMRB will decide whether or not to take up the issues related to potential merger of NIAAA and NIDA • If the SMRB decides to consider this issue further, next steps will be decided at the meeting • No decision regarding the organization will be made at the April, 2009 meeting

More Related